5
Views
17
CrossRef citations to date
0
Altmetric
Original Article

Scatter Factor Regulates Vascular Endothelial Cell Motility

, &
Pages 647-650 | Published online: 11 Jun 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Xiangdong Liu, Wenqing Yao, Robert C Newton & Peggy A Scherle. (2008) Targeting the c-MET signaling pathway for cancer therapy. Expert Opinion on Investigational Drugs 17:7, pages 997-1011.
Read now

Articles from other publishers (15)

Sioned Owen, Andrew Sanders, Malcolm Mason & Wen Jiang. (2016) Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro. International Journal of Oncology.
Crossref
Jen-Hao Chen, Chew-Wun Wu, Hwa-Li Kao, Hwey-May Chang, Anna F-Y. Li, Tsung-Yun Liu & Chin-Wen Chi. (2006) Effects of COX-2 inhibitor on growth of human gastric cancer cells and its relation to hepatocyte growth factor. Cancer Letters 239:2, pages 263-270.
Crossref
Sibylle Karcher, Hans-Herbert Steiner, Rezvan Ahmadi, Saida Zoubaa, Gergely Vasvari, Harry Bauer, Andreas Unterberg & Christel Herold-Mende. (2006) Different angiogenic phenotypes in primary and secondary glioblastomas. International Journal of Cancer 118:9, pages 2182-2189.
Crossref
Heather McKinnon, Ermanno Gherardi, Michael Reidy & David Bowyer. (2006) Hepatocyte Growth Factor/Scatter Factor and MET Are Involved in Arterial Repair and Atherogenesis. The American Journal of Pathology 168:1, pages 340-348.
Crossref
James G. Christensen, Jon Burrows & Ravi Salgia. (2005) c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention. Cancer Letters 225:1, pages 1-26.
Crossref
J.-H. Chen, T.-Y. Liu, C.-W. Wu & C.-W. Chi. (2001) Nonsteroidal anti-inflammatory drugs for treatment of advanced gastric cancer: cyclooxygenase-2 is involved in hepatocyte growth factor mediated tumor developmentand progression. Medical Hypotheses 57:4, pages 503-505.
Crossref
Robbert van der Voort, Taher E.I. Taher, Patrick W.B. Derksen, Marcel Spaargaren, Ronald van der Neut & Steven T. Pals. 2000. 39 90 .
Osamu Noguchi, Nobuyuki Enomoto, Takaaki Ikeda, Fumie Kobayashi, Fumiaki Marumo & Chifumi Sato. (1996) Gene expressions of c-met and hepatocyte growth factor in chronic liver disease and hepatocellular carcinoma. Journal of Hepatology 24:3, pages 286-292.
Crossref
Noël Bouck, Veronica Stellmach & Stephanie C. Hsu. 1996. 135 174 .
P. J. Polverini & B. J. Nickoloff. 1995. Epithelial-Mesenchymal Interactions in Cancer. Epithelial-Mesenchymal Interactions in Cancer 51 67 .
G MurugesanG SaP L Fox. (1994) High-density lipoprotein stimulates endothelial cell movement by a mechanism distinct from basic fibroblast growth factor.. Circulation Research 74:6, pages 1149-1156.
Crossref
Nobuyuki Shima & Kanji Higashio. 1994. Liver Carcinogenesis. Liver Carcinogenesis 55 70 .
Mark Johnson, George Koukoulis, Kunio Matsumoto, Toshikazu Nakamura & Anand Iyer. (1993) Hepatocyte growth factor induces proliferation and morphogenesis in nonparenchymal epithelial liver cells. Hepatology 17:6, pages 1052-1061.
Crossref
R. M. Warn. (1991) The Janus factor. Nature 353:6339, pages 20-21.
Crossref
Eliot M. Rosen, Derek Grant, Hynta Kleinman, Susan Jaken, Maribeth A. Donovan, Eva Setter, Peter M. Luckett, William Carley, Madhu Bhargava & Itzhak D. Goldberg. 1991. Cell Motility Factors. Cell Motility Factors 76 88 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.